Interviews

Daniel Mitchell

2025-04-10

In Latin America, only Brazil and Colombia are currently engaged in chemical recycling at scale. We have facilities processing waste into feedstock, which is then refined and used again in plastic production. Potential investments could add another 100,000 tons in capacity.

Manuel Diaz

Director General

The Latin American Petrochemical and Chemical Association (APLA)

2025-04-10

Nearshoring is a growing opportunity, with Mexico being the main beneficiary. The country is attracting investments in personal care, pharmaceuticals, automotive, and other industries. However, it likely won’t absorb all the demand, leaving room for countries like Colombia, Brazil, and Argentina to benefit.

Jan Krueder

CEO

Química Anastacio & Anastacio Overseas

2025-04-10

Agriculture is a major market in Brazil, as we are the top exporter of commodities like sugar, coffee, and soybean. We expect it to remain a key area for growth in 2025 as demand continues to grow in Brazil and Latin America.

Paco Koudstaal & Thies Grage

Regional Director Latin America & Head of Innovation & Sustainability

HOYER Group

2025-04-10

TG: The logistics industry is hard to decarbonize. Our emissions come from road transport (our own trucks and suppliers’ fleets) and ocean shipping. In Europe, we've made progress by increasing intermodal transport—using rail and short-sea shipping to cut road emissions.

Cecilia Ma

Investment Manager

Norrsken VC

2025-04-10

For us, an impact unicorn is a company where there is a direct relationship between the revenue it generates and the impact it creates. It is not just about doing no harm or contributing some good; the core business model ensures that for every dollar earned, there is a corresponding positive impact. If the company succeeds, it is creating significant value for society.

Abdulkader Rahmo

Co-Founder, President & CEO

SMSbiotech

2025-04-09

SMSbiotech is a biotech company based in California, specializing in regenerative medicine through the discovery and development of a novel human stem cell known as the Small Mobile Stem (SMS) cell.

Prof. Edith Heard

Director General

European Molecular Biology Laboratory (EMBL)

2025-04-09

The European Molecular Biology Laboratory (EMBL) is an intergovernmental research organization that conducts cutting-edge scientific research in molecular biology, provides services and infrastructure, trains scientists, and fosters collaboration across Europe to address global challenges in health and the environment.

Juan Francisco Politi, & Néstor De Cesare

VP & President

Allaria Fondos

2025-04-09

Argentina needs to improve productivity and show the world that a certain policy direction will stick through time. The government has managed a first batch of reform even in a minority, but more profound sustainable change requires political compromise and wider social consensus.

Stefan König

CEO

Merz Therapeutics

2025-04-08

Merz Therapeutics is a pharmaceutical company specializing in the development and commercialization of treatments in the areas of specialty neurology and movement disorders.

Alessandro Maselli

President & CEO

Catalent

2025-04-08

Catalent is a global leader in providing advanced drug development, delivery, and manufacturing solutions as a Contract Development and Manufacturing Organization (CDMO), specializing in biologics, gene therapies, and other innovative modalities.

Pagina 7 din 166